LBPHARMA.US: Keyword Density Checker

Total words: 893 | 2-word phrases: 236 | 3-word phrases: 253 | 4-word phrases: 259

PAGE INFO

Title	Try to keep the title under 60 characters (77 characters) LB Pharmaceuticals - Developing Novel Therapies for Neuropsychiatric Diseases
Description	Try to keep the meta description between 50 - 160 characters (184 characters) We are building a pipeline that leverages the broad therapeutic potential of our lead product candidate, LB-102, for the treatment of schizophrenia and other neuropsychiatric diseases.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (56 characters) Developing Novel Therapies for Neuropsychiatric Diseases

#	Keyword	Frequency	Density
1	for the treatment	3	1.19%
2	developing novel therapies	3	1.19%
3	of neuropsychiatric diseases	2	0.79%
4	the broad therapeutic	2	0.79%
5	leverages the broad	2	0.79%
6	of our lead	2	0.79%
7	biopharmaceutical company developing	2	0.79%
8	a pipeline that	2	0.79%
9	building a pipeline	2	0.79%
10	are building a	2	0.79%
11	company developing novel	2	0.79%
12	neuropsychiatric diseases learn	2	0.79%
13	our lead product	2	0.79%
14	diseases learn more	2	0.79%
15	approved by the	2	0.79%
16	broad therapeutic potential	2	0.79%
17	careers contact us	2	0.79%
18	news careers contact	2	0.79%
19	patientsproviders news careers	2	0.79%
20	board pipeline publications	2	0.79%
21	advisory board pipeline	2	0.79%
22	scientific advisory board	2	0.79%
23	leadership scientific advisory	2	0.79%
24	the treatment of	2	0.79%
25	more about lb	2	0.79%
26	treat cns disorders	1	0.40%
27	lifesaving drugs to	1	0.40%
28	to treat cns	1	0.40%
29	of lifesaving drugs	1	0.40%
30	versions of lifesaving	1	0.40%

#	Keyword	Frequency	Density
1	biopharmaceutical company developing novel	2	0.77%
2	neuropsychiatric diseases learn more	2	0.77%
3	are building a pipeline	2	0.77%
4	building a pipeline that	2	0.77%
5	news careers contact us	2	0.77%
6	patientsproviders news careers contact	2	0.77%
7	leverages the broad therapeutic	2	0.77%
8	the broad therapeutic potential	2	0.77%
9	advisory board pipeline publications	2	0.77%
10	scientific advisory board pipeline	2	0.77%
11	leadership scientific advisory board	2	0.77%
12	company developing novel therapies	2	0.77%
13	for the treatment of	2	0.77%
14	of our lead product	2	0.77%
15	are also developing other	1	0.39%
16	for the us market	1	0.39%
17	the us market we	1	0.39%
18	us market we are	1	0.39%
19	market we are also	1	0.39%
20	we are also developing	1	0.39%
21	of lifesaving drugs to	1	0.39%
22	also developing other usmarket	1	0.39%
23	focused versions of lifesaving	1	0.39%
24	versions of lifesaving drugs	1	0.39%
25	atypical approved to treat	1	0.39%
26	lifesaving drugs to treat	1	0.39%
27	drugs to treat cns	1	0.39%
28	to treat cns disorders	1	0.39%
29	treat cns disorders that	1	0.39%
30	cns disorders that are	1	0.39%
31	available overseas but currently	1	0.39%
32	overseas but currently not	1	0.39%
33	but currently not approved	1	0.39%
34	currently not approved by	1	0.39%
35	not approved by the	1	0.39%
36	schizophrenia for the us	1	0.39%
37	lb102 would be the	1	0.39%
38	benzamide atypical approved to	1	0.39%
39	the companys growth is	1	0.39%
40	explore our clinical trials	1	0.39%